GL1X · GenesisL1 explorer

MolNFT v1 · #91681 · protein

Crystal structure of the CDK2 in complex with thiazolylpyrimidine inhibitor

4FKL · Cyclin-dependent kinase 2: “Crystal structure of the CDK2 in complex with thiazolylpyrimidine inhibitor”. X-ray diffraction, 2 ligands (ACE, CK2), 1 pocket (best druggability 0.70). MolNFT v1 #91681 on GenesisL1: 3D structure…

PDB
4FKL
Type
protein
Length
290 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cyclin-dependent kinase 2
EC
2.7.11.22
UniProt
P24941
Ligands
ACE, CK2
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACyclin-dependent kinase 2 (EC 2.7.11.22)protein29035% helix, 16% strandP24941

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A
  • CK2 · 4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13270.700.8347CK2

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4FKL · Crystal structure of the cdk2 in complex with thiazolylpyrimidine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.